INTRODUCTION {#s1}
============

In China, Gastric cancer (GCa) is the second most common cancer, with an estimated 679,100 new GCa cases and 498,000 deaths in 2015, accounting for 15.8% of the cancer cases and 17.7% of cancer deaths, respectively \[[@R1]\]. However, the underlying mechanism of its carcinogenesis is still not fully understood. The environmental factors, such as toacco smoking, alcohol use, *helicobacter pylori* (*HP*) infection, as well as low-penetrance susceptibility genes are believed to be crucial in the etiology of GCa development \[[@R2], [@R3]\]. In addition, emerging genomic studies in recent years have identified a few genetic variants associated with GCa risk \[[@R4]--[@R8]\]; however, it is necessary to validate those previous reported genetic risk factors in the external populations.

miRNA, a small non-coding RNA molecule consisting of \~22 nucleotides, has crucial biological functions in post-transcriptional regulation of genes, as well as cell differentiation, proliferation, and apoptosis \[[@R9]--[@R12]\]. All these functions have critical roles in the development of cancer, including gastric cancer \[[@R13], [@R14]\]. Notebly, single nucleotide polymorphisms (SNPs) in miRNA genes could repress the efficiency of miRNA transcript processing \[[@R15]\]. The SNP rs2910164 within *microRNA-146a* (miR-146a) is placed in the passenger strand, of which the C allele probably causes hairpins mispaired \[[@R16]\] and thus, affect miR-146a maturing process \[[@R17]\]. This miRNA SNP has been extensively explored to cancer risk in scientific community \[[@R17]--[@R20]\]. The SNP rs2910164 G\>C has been reported which is associated with the increased risk of GCa \[[@R21], [@R22]\]. However, the results are inconclusive, espicially among Asian populations \[[@R21], [@R23]--[@R25]\], which probably due to the moderate effect size or small sample size in each single study. Recently, an updated meta-analysis in this field suggested a correlation between this SNP and increased GCa risk \[[@R26]\]. However, due to insufficient sample size of each recruited study and potential heterogeneity among these study cohorts, the results of meta-analysis should be interpreted with caution. Therefore, we conducted a large GCa study of 1,125 cases and 1,196 controls in a well-established gastric cancer study cohort to validate this association in an eastern Chinese population.

RESULTS {#s2}
=======

Table [1](#T1){ref-type="table"} described the population characteristics of this hospital-based case-control study, as reported previously \[[@R27]\]. Briefly, 1,125 GCa cases were averagely aged at 58.60±11.36 years, 71.1% male; 1,196 age and gender matched cancer-free controls were aged at 58.62 ± 11.75 years, and 69.1% were male. Age, gender, smoking status, as well as drinking status were further adjusted for the following multivariate analysis.

###### Distributions of selected variables in gastric cancer cases and cancer-free controls

  Variables                                   Cases N(%)      Controls N(%)   *P*[^a^](#tfn_001){ref-type="table-fn"}
  ------------------------------------------- --------------- --------------- -----------------------------------------
  All subjects                                1,125(100)      1,196 (100)     
  Age, yr                                                                     0.557
   Range                                      21-86           22-86           
   Mean[^b^](#tfn_002){ref-type="table-fn"}   58.60 ± 11.36   58.62 ± 11.75   
   ≤ 50                                       234 (20.8)      271 (22.7)      
   51-60                                      383 (34.0)      384 (32.1)      
   61-70                                      339 (30.1)      372 (31.1)      
   \>70                                       169 (15.0)      169 (14.1)      
  Sex                                                                         0.282
   Males                                      800 (71.1)      826 (69.1)      
   Females                                    325 (28.9)      370 (30.9)      
  Smoking status                                                              \<0.0001
   Never                                      686 (61.0)      610 (51.0)      
   Former                                     17 (1.5)        120 (10.0)      
   Current                                    422 (37.5)      466 (39.0)      
  Drinking status                                                             0.008
   Yes                                        270 (24.0)      345 (28.8)      
   No                                         855 (76.0)      851 (71.2)      
  Pack-years                                                                  \<0.0001
   0                                          686 (61.0)      610 (51.0)      
   ≤ 25 (mean)                                227 (20.2)      355 (29.7)      
   \> 25 (mean)                               212 (18.8)      231 (19.3)      
  Tumor site                                                                  
   GCA                                        305 (27.1)      ---             
   NGCA                                       820 (72.9)      ---             

Abbreviations: GCA, gastric cardia adenocarcinoma; NGCA, non-gastric cardia adenocarcinoma

Two-sided χ^2^ test for distributions between cases and controls.

Age was described as mean ± SD.

Allele frequencies of the rs2910164 A\>G SNP were listed by cases and controls in Table [2](#T2){ref-type="table"}, as well as the association between this SNP and GCa risk. SNP rs2910164 showed a non-significant association with GCa risk in our study population \[co-dominant genetic model: heterozygotes (CG) vs. wild-type (CC), odds ratio (OR) = 0.99, 95% confidence interval (95%CI): 0.83-1.19; homozygotes (GG) vs. CC, OR = 1.03, 95%CI: 0.81-1.32; dominant genetic model: (CG+GG) vs. CC, OR = 1.00, 95%CI = 0.84-1.19; recessive genetic model: GG vs. (CG+CC), OR = 1.04, 95%CI = 0.83-1.29\]. Stratification analyses according to age, gender, smoking, drinking, and tumor location indicated consistent results (Table [3](#T3){ref-type="table"}).

###### Logistic regression analysis of associations between the genotypes of *miR146A* and gastric cancer risk

  Variants                 Genotypes          Cases (N=1,125)   Controls (N=1,196)   *P*[a](#tfn_003){ref-type="table-fn"}     Crude OR (95% CI)   *P*     Adjusted OR (95% CI)[b](#tfn_004){ref-type="table-fn"}   *P*[b](#tfn_004){ref-type="table-fn"}
  ------------------------ ------------------ ----------------- -------------------- ----------------------------------------- ------------------- ------- -------------------------------------------------------- ---------------------------------------
  Rs2910164                                                                                                                                                                                                         
                           CC                 397 (35.3)        420 (35.1)           0.946[c](#tfn_005){ref-type="table-fn"}   1.00                        1.00                                                     
                           CG                 536 (47.6)        577 (48.2)                                                     0.98 (0.82-1.18)    0.850   0.99 (0.83-1.19)                                         0.922
                           GG                 192 (17.1)        199 (16.6)                                                     1.02 (0.80-1.30)    0.868   1.03 (0.81-1.32)                                         0.801
                           CG/GG              728 (64.7)        776 (64.9)           0.931[d](#tfn_006){ref-type="table-fn"}   0.99 (0.84-1.18)    0.931   1.00 (0.84-1.19)                                         0.988
  Additive genetic model   1.01 (0.90-1.13)   0.930             1.01 (0.90-1.14)     0.853                                                                                                                          
                           CC/CG              933 (82.9)        997 (83.4)                                                     1.00                        1.00                                                     
                           GG                 192 (17.1)        199 (16.6)           0.783[e](#tfn_007){ref-type="table-fn"}   1.03 (0.83-1.28)    0.783   1.04 (0.83-1.29)                                         0.744

Chi square test for genotype distributions between cases and controls

Adjusted for age, sex, smoking and drinking status in logistic regression models

for additive genetic models;

for dominant genetic models;

for recessive genetic models.

###### Stratification analysis for associations between *miR146A* variant genotypes and gastric cancer risk

  Variables         Rs2910164 (Cases/Controls)   Crude OR (95% CI)   *P*       Adjusted OR[a](#tfn_008){ref-type="table-fn"} (95% CI)   *P*[a](#tfn_008){ref-type="table-fn"}                              
  ----------------- ---------------------------- ------------------- --------- -------------------------------------------------------- --------------------------------------- ------- ------------------ -------
  Age, yr                                                                                                                                                                                                  
   ≤59 (median)     202/217                      34.9/35.6           376/393   65.1/64.4                                                1.03 (0.81-1.30)                        0.822   1.04 (0.82-1.32)   0.769
   \>59 (median)    195/203                      35.6/34.6           352/383   64.4/65.4                                                0.96 (0.75-1.22)                        0.723   0.95 (0.74-1.22)   0.677
  Gender                                                                                                                                                                                                   
   Males            291/284                      36.4/34.4           509/542   63.6/65.6                                                0.92 (0.75-1.12)                        0.401   0.93 (0.76-1.14)   0.496
   Females          106/136                      32.6/36.8           219/234   67.4/63.2                                                1.20 (0.88-1.64)                        0.253   1.19 (0.86-1.63)   0.291
  Smoking status                                                                                                                                                                                           
   Never            249/214                      36.3/35.1           437/396   63.7/64.9                                                0.95 (0.76-1.19)                        0.649   0.97 (0.77-1.22)   0.764
   Former           6/39                         35.3/32.5           11/81     64.7/67.5                                                0.88 (0.30-2.56)                        0.819   1.10 (0.36-3.36)   0.872
   Current          142/167                      33.6/35.8           280/299   66.4/64.2                                                1.10 (0.84-1.45)                        0.495   1.09 (0.82-1.44)   0.560
  Drinking status                                                                                                                                                                                          
   Never            309/300                      36.1/35.3           546/551   63.9/64.7                                                0.96 (0.79-1.17)                        0.702   0.97 (0.80-1.19)   0.771
   Ever             88/120                       32.6/34.8           182/225   67.4/65.2                                                1.10 (0.79-1.55)                        0.569   1.10 (0.79-1.55)   0.572
  Pack-years                                                                                                                                                                                               
   0                249/214                      36.3/35.1           437/396   63.7/64.9                                                0.95 (0.76-1.19)                        0.649   0.96 (0.76-1.21)   0.726
   ≤25 (mean)       72/130                       31.7/36.6           155/225   68.3/63.4                                                1.24 (0.87-1.77)                        0.226   1.20 (0.84-1.73)   0.322
   \>25 (mean)      76/76                        35.8/32.9           136/155   64.2/67.1                                                0.88 (0.59-1.30)                        0.514   0.97 (0.64-1.46)   0.877
  Tumor site                                                                                                                                                                                               
   GCA              110/420                      36.1/35.1           195/776   63.9/64.9                                                0.96 (0.74-1.25)                        0.756   0.96 (0.74-1.25)   0.752
   NGCA             287/420                      35.0/35.1           533/776   65.0/64.9                                                1.01 (0.83-1.21)                        0.957   1.01 (0.84-1.22)   0.901

Abbreviations: GCA, gasric cardia adenocarcinoma; NGCA, non-gastric cardia adenocarcinoma

Obtained in logistic regression models with adjustment for age, sex, smoking and drinking status

DISCUSSION {#s3}
==========

Genetic susceptibility has been a research focus in cancer studies. Recently, *miR-146a* has drawn an increasing attention for its potential connection to several types of cancers, including gastric cancer. Several studies have indicated the common SNP rs2910164 in *miR-146a* as a moderate risk allele for gastric cancer \[[@R26], [@R28]\]. However, the results should be intepreted with causion, largely due to inadequate sample size in each independent study. Our study was performed with a relatively large sample size in a well-established gastric cancer study cohort among eastern Chinese population. This study showed an insignificant association, as well as among a series of subgroup analyses. The results suggest a considerably heterogeneous effect of this SNP among various cancer types. On the other hand, the observed association may be due to chance.

We acknowledge some limitations of the present study. First, although age, sex, smoking and drinking status, and tumor site were taken into consideration for subgroup analysis, other important risk factors, such as diet, microbial virulence, and HP infection, were missing in the study, which might also contribute to the etiology of GCa \[[@R29], [@R30]\]. Second, new classification of GCa tumor types, which was not available for the patients diagnosed years ago, is also important and may have an interaction effect with genetic variants on gastric cancer risk \[[@R31]\]. Third, the number of cases was largely reduced in the stratified analysis, which may lead to an insufficient statistical power.

In summary, these results suggest that the SNP rs2910164 of miR-146a may not be associated with the risk of GCa in this Chinese population. However, analysis of this SNP incorporating diet, *HP* infection status or Lauren classification probably provide an updated result.

MATERIALS AND METHODS {#s4}
=====================

Study subjects {#s4_1}
--------------

This study included patients who were recruited from our ongoing molecular epidemiology study of GCa, and the cases and controls were described previously \[[@R27], [@R32], [@R33]\]. Briefly, 1,125 unrelated ethnic Han Chinese patients with newly diagnosed and histopathologically confirmed primary gastric cardia adenocarcinoma and non-gastric cardia adenocarcinoma (NGCA) were recruited from Fudan University Shanghai Cancer Center (FUSCC) in Eastern China between January 2009 and March 2011. Patients other than histopathologically confirmed primary GCa were excluded. In addition, 1,196 age and sex-matched cancer-free ethnic Han Chinese controls were recruited from the Taizhou Longitudinal (TZL) study conducted at the same time period in Eastern China as described previously \[[@R34]\]. Blood samples from both GCa patients and cancer-free controls were provided by the tissue bank of FUSCC and the TZL study, respectively. All participants had signed a written informed consent for donating their biological samples to the tissue bank for scientific research. Demographic data and environmental exposure history of each participants were collected. The overall response rate was approximately 91% for cases and 90% for controls. This research protocol was approved by the FUSCC Institutional Ethics Review Board.

SNP genotyping {#s4_2}
--------------

According to a relevant protocol, we extracted genomic DNA from peripheral blood. The rs2910164 SNP was genotyped by the TaqMan assay with ABI7900HT real-time PCR system (Applied Biosystems) as reported previously \[[@R27]\]. Participants\' status was unrevealed in the genotyping process. As recommend by the company, four negative controls (without DNA templates) and two duplicated samples were included in each 384-plate for the quality control. The assays were repeated for 5% of the samples, and the results were 100% concordant.

Statistical methods {#s4_3}
-------------------

The χ^2^ test was used to assess differences in the distributions of demographic characteristics between cases and controls. The association between SNP and GCa risk was assessed by odds ratio (OR) and 95% confidence intervals (CIs) in heterozygous (CG vs. CC), homozygous (GG vs. CC), dominant (CG+GG vs. CC), recessive (GG vs. CG+CC), and additive (G vs. C) genetic models, respectively. OR values were calculated by both univariate and multivariate logistic regression models. Moreover, logistic regression tests for each genetic model were adjusted for age, sex, drinking and smoking status. Furthermore, the association between the *miR-146a* rs2910164 SNP and GCa risk was also stratified by age, sex, smoking or drinking status, and primary tumor site. All statistical process above was achieved by SAS Version 9.1 software (SAS Institute, Cary, NC, USA).
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